A Single-centre, Randomised, Double-blind, Placebo-controlled, Parallel Group Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Nutritional and metabolic diseases; Obesity
- Focus Pharmacodynamics
- Sponsors Novo Nordisk
- 03 Mar 2017 Status changed from active, no longer recruiting to completed.
- 16 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 04 Apr 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.